Cardiovascular safety of antihyperglycemic therapy intensification

• Alexander S. Ametov
• Natalya A. Chernikova
• E.А. Ermakova

AbstractType 2 diabetes mellitus is a chronic, advanced disease that can lead to development of vascular events that in turn can significantly increase risk of cardiovascular mortality. However some researches prove importance of glycemic control for decreasing the risk of diabetic vascular events progressing, and others argue to mortality increasing in Intensive glycemic control group. Thus, for decreasing the risk ofсardiovascular complications in group of type 2 diabetes mellitus it is necessary to use the medications that have sufficient evidential base.

Keywords:type 2 diabetes mellitus, cardiovascular complications, microangiopathy, macroangiopathy, hyperglycaemia, hypoglycemia, sulfonylurea medications

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)